Thrombolytic therapy in venous occlusive disease

J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):73S-77S. doi: 10.1016/s1051-0443(95)71252-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angioplasty, Balloon / instrumentation
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Equipment Design
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Phlebography / instrumentation
  • Stents
  • Thrombolytic Therapy* / instrumentation
  • Thrombophlebitis / diagnostic imaging
  • Thrombophlebitis / drug therapy*
  • Thrombophlebitis / etiology
  • Urokinase-Type Plasminogen Activator / administration & dosage*
  • Urokinase-Type Plasminogen Activator / adverse effects

Substances

  • Fibrinolytic Agents
  • Urokinase-Type Plasminogen Activator